Powder flowability improver and method for improving powder flowability
Calcium carbonate with a 0.4 μm particle size improves powder fluidity and nutrition, addressing the limitations of conventional improvers by enhancing uniformity and stability in formulations.
Patent Information
- Application Number
- JP2020184736
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-11-04
- Publication Date
- 2024-12-09
- Estimated Expiration
- 2040-11-04
AI Technical Summary
Conventional fluidity improvers like silicon dioxide and talc do not provide sufficient fluidity improvement and often lead to variations in raw material content and manufacturing troubles during formulation processes such as tableting and capsule filling, while also lacking nutritional benefits.
A powder fluidity improver made of calcium carbonate with an average particle size of 0.4 μm or less, which enhances fluidity and provides nutritional benefits when added in 0.5 to 10% by mass to powder compositions.
The calcium carbonate improver achieves equal or better fluidity improvement than conventional agents, reduces raw material variations, and enhances nutritional value, stabilizing formulations like hard capsules and tablets.
Smart Images

Figure 0007596121000007 
Figure 0007596121000008 
Figure 0007596121000009
Abstract
Description
[Technical field]
[0001] The present invention relates to a powder flowability improver and a method for improving powder flowability, and more particularly to a powder flowability improver and a method for improving powder flowability used in the fields of medicines, health foods, and the like. [Background technology]
[0002] A flow improver is an additive used to reduce the adhesive force of powder components and improve their flowability. In the manufacture of pharmaceuticals, powders, granular foods, etc., when using powdered or granular raw materials with high cohesive properties, the raw materials tend to be insufficiently mixed. For this reason, there may be variations in the content and mass of each raw material in each manufactured formulation or product. In such cases, manufacturing problems may also occur during the formulation process, i.e., tableting and capsule filling. In such cases, flow improvers are added to improve the flowability of powders and granules, thereby solving the above problems. Conventionally, silicon dioxide, talc, and the like have been used as such flow improvers, as shown in Patent Document 1.
[0003] Furthermore, Patent Document 2 discloses a flowability improver for powder products, which is obtained by adjusting carbohydrates so that the average particle size, as measured using a laser diffraction / scattering particle size distribution analyzer, is 0.1 μm to 20 μm for use in foods. [Prior art documents] [Patent documents]
[0004] [Patent Document 1] JP 2003-81876 A [Patent Document 2] Japanese Patent Application Publication No. 4-295425 Summary of the Invention [Problem to be solved by the invention]
[0005] The object of the present invention is to provide a flowability improving agent which has a flowability improving effect equal to or greater than that of conventional flowability improving agents such as silicon dioxide, silicic acid, talc, etc., and further has a nutritional improving effect. [Means for solving the problem]
[0006] Means for Solving the Problems The present inventors have conducted intensive research into the above-mentioned problems and have discovered that the fluidity of powder can be improved by adding calcium carbonate having a specific average particle size, thereby completing the present invention.
[0007] That is, the present invention provides the following [1] to [5]. [1] A powder flow improver consisting of calcium carbonate with an average particle size of 0.4 μm or less. This can provide a fluidity-promoting effect equal to or greater than that of conventional fluidity improvers. In addition, the inclusion of calcium can improve the nutritional value of the powder to which it is added. [2] A powder composition comprising the powder flow improver according to [1] in an amount of 0.5 to 10 mass %. This makes it possible to obtain a powder composition that exhibits a more excellent effect of improving powder flowability. A hard capsule formulation comprising the flow improver of [3] or the powder composition of [2]. This makes it possible to obtain a hard capsule formulation with excellent uniformity in the amount of raw material filled in the hard capsule. [4] A tablet comprising the flow improver of [1] or the powder composition of [2]. According to this, in tablet production, the amount of raw material filled into the die is highly uniform, so that tablets with excellent grain weight uniformity can be obtained. [5] A method for improving the fluidity of a powder, comprising adding 0.5 to 10 mass % of calcium carbonate having an average particle size of 0.4 μm or less to the total amount of the powder. This can provide a fluidity-promoting effect equal to or greater than that of conventional fluidity-improving agents. In addition, the addition of calcium can improve the nutritional value of the powder composition to which it is added. Effect of the Invention
[0008] According to the present invention, it is possible to provide a flowability improving agent that has a flowability improving effect equal to or greater than that of conventional flowability improving agents such as silicon dioxide, silicic acid, talc, etc., and also has a nutritional improving effect. [Brief description of the drawings]
[0009] [Figure 1] The results of testing the flow improvement effect of a conventional flow improver and calcium carbonate using a powder flow tester are shown below. [Diagram 2] 1 shows a scanning electron microscope image of calcium carbonate particles. [Diagram 3] 1 shows a spectrum of calcium carbonate particles measured by a powder X-ray diffraction apparatus. [Figure 4] 4 shows the flowability improving effect depending on the content of the flowability improver of the present invention in the powder composition. [Diagram 5] 1 shows the results of testing the flow-improving effect of the flow-improving agent of the present invention on compositions containing other than maltitol. [Figure 6] The results of testing the effect of microparticulated calcium carbonate in improving fluidity are shown below. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010] Hereinafter, embodiments of the powder flowability improver, powder composition, method for improving powder fluidity, hard capsule formulation, and tablet according to the present invention will be described in detail. The flow improver, powder composition, method for improving powder fluidity, hard capsule formulation, and tablet described in the embodiments are merely examples to explain the present invention, and are not intended to be limiting.
[0011] [Flow improver for powders] The powder flow improver of the present invention is made of calcium carbonate having an average particle size of 0.4 μm or less. When calcium carbonate having an average particle size of 0.4 μm or less is contained in a powder, it exhibits an excellent effect of improving the flowability of the powder, and can obtain a flowability promoting effect equal to or greater than that of conventional flow improvers. This can suppress the variation in the content of each raw material in each manufactured preparation or product and the variation in the mass of the preparation, and further suppress manufacturing problems during formulation. In addition, since it further contains calcium, it can improve the nutrition of the powder to which it is added. In addition, it is known that general compounds have a large surface energy of particles in a fine state and aggregate over time after grinding, but calcium carbonate can exist stably as a powder of fine particles of 0.4 μm or less.
[0012] The average particle size of calcium carbonate used as the flowability improver of the present invention is 0.4 μm or less. From the viewpoint of the effect as a flowability improver, the upper limit is preferably 0.2 μm or less, more preferably 0.1 μm or less, and even more preferably 0.05 μm or less. From the viewpoint of the production of calcium carbonate particles, the lower limit is preferably 0.005 μm or more, and more preferably 0.01 μm or more. The average particle size of calcium carbonate can be measured by a laser diffraction device. Examples of the laser diffraction device include a laser diffraction / scattering type particle size distribution measuring device (Horiba, Ltd.). In particular, when measuring the average particle size of calcium carbonate having an average particle size of 0.1 μm or less, which is difficult to measure by a laser diffraction device, it is preferable to measure it by a dynamic light scattering device (DLS). Examples of the dynamic light scattering device include a zeta potential / particle size measuring device ELSZ-1000 (manufactured by Otsuka Electronics Co., Ltd.).
[0013] The particle shape of calcium carbonate is not particularly limited, but spherical particles, rock-like particles, needle-like particles, porous particles, etc. are used. Among these, spherical particles are preferred. The type of calcium carbonate is not particularly limited, but precipitated calcium carbonate and heavy calcium carbonate are used. Precipitated calcium carbonate includes light calcium carbonate, semi-colloid calcium carbonate, and colloidal calcium carbonate. Among these, from the viewpoint of making the average particle size smaller, precipitated calcium carbonate is preferred, semi-colloid calcium carbonate or colloidal calcium carbonate is more preferred, and colloidal calcium carbonate is even more preferred.
[0014] The method for preparing the flow improver of the present invention is not particularly limited, but it can be obtained by a method in which calcium carbonate particles are further converted into fine particles by a physical method such as pulverization. For such pulverization, a device such as a bead mill or a jet mill can be used. Such a device includes a Dyno Mill MULTI LAB type (manufactured by Willy & Bachofen Co., Ltd.). In addition, a commercially available calcium carbonate product can be used as the flow improver of the present invention. Such a commercially available product includes Cal Essen-P (manufactured by Shiraishi Calcium Co., Ltd.).
[0015] The flowability improver of the present invention is used for powders used for pharmaceuticals, foods, veterinary medicines, feeds, etc. The flowability improver of the present invention exerts a large flowability improving effect when used for powders with poor flowability. Such powders include crystalline cellulose, maltitol, starch, etc. The flowability improver of the present invention is particularly suitable for improving the flowability of crystalline cellulose.
[0016] The effect of the flowability improver of the present invention can be evaluated by, but is not limited to, conventional indices of powder flowability. Such indices include flow function (ffc), flow index, angle of repose, collapse angle, difference angle, etc. The flow function can be calculated from the ratio of maximum principal stress to uniaxial collapse stress (maximum principal stress / uniaxial collapse stress) measured by a device such as a powder flow tester (manufactured by BROOK FIELD).
[0017] Measurements using a powder flow tester are carried out as follows. The sample is filled into the measurement cell and set into the device, where it is compressed to the set pressure (maximum principal stress). The torque (uniaxial collapse stress) is measured when the measurement cell is rotated in a certain direction (1 rotation / h). A smaller uniaxial collapse stress value indicates higher fluidity. The flow function is defined as maximum principal stress / uniaxial collapse stress, and a higher value indicates higher fluidity.
[0018] [Powder composition] The powder composition of the present invention is a powder composition containing 0.5-10% by mass of the powder flow improver of the present invention. By adding 0.5-10% by mass of the powder flow improver of the present invention to the powder composition, the flowability of the powder composition is further improved. This can suppress the variation in the content of each raw material in each manufactured preparation or product and the variation in the mass of the preparation, and further suppress production problems during preparation, i.e., tableting and capsule filling. Furthermore, since it contains calcium, nutrition is improved. From the viewpoint of improving the fluidity, the upper limit is preferably 8% by mass or less, more preferably 6% by mass or less, and even more preferably 5% by mass or less. From the viewpoint of improving the fluidity, the lower limit is 0.5% by mass or more, preferably 1% by mass or more, more preferably 2% by mass or more, and even more preferably 3% by mass or more.
[0019] The amount of the flow improver in the powder composition of the present invention can be determined by dispersing the powder composition, tablet, or hard capsule in water, passing the mixture through a 0.4 um filter, and measuring the amount of calcium carbonate in the filtrate. The above content is measured, for example, in the range of 0.5 to 10% by mass, as the mixed powder in the filtrate, with the upper limit being preferably 8% by mass or less, more preferably 6% by mass or less, and even more preferably 5% by mass or less, and the lower limit being 0.5% by mass or more, preferably 1% by mass or more, more preferably 2% by mass or more, and even more preferably 3% by mass or more.
[0020] (Use as flow improver and powder composition) The flowability improver or powder composition of the present invention is used for applications such as medicines, foods, veterinary medicines, and feeds. The form of use is not particularly limited as long as it is acceptable for these applications, and examples thereof include tablets such as sugar-coated tablets, buccal tablets, coated tablets, and chewable tablets, pills, powders, soft capsules, hard capsules, granules, lozenges, processed foods, health foods (nutritional supplements, nutritional functional foods, foods for the sick, foods for specified health uses, and foods with functional claims), supplements, foods for the sick (hospital foods, foods for sick people, and foods for nursing care), confectionery, oils and fats, dairy products, retort foods, microwave foods, frozen foods, seasonings, health supplements, beverages, and nutritional drinks. The flowability improver of the present invention is significantly effective in suppressing the occurrence of manufacturing problems during formulation, i.e., during tableting and capsule filling, in the production of hard capsules and tablets.
[0021] (Other Ingredients) The powder composition of the present invention may contain active ingredients and additives in addition to the flowability improver of the present invention depending on its application. Specific examples of additives include excipients, binders, disintegrants, stabilizers, preservatives, colorants, etc., which are added depending on the application of the powder composition. In addition, the powder composition may contain flowability improvers other than the flowability improver of the present invention.
[0022] The active ingredient is not particularly limited as long as it exhibits efficacy and effect and is acceptable for use in medicines, foods, veterinary medicines, feeds, and the like. Examples of the active ingredient include medicinal ingredients and functional ingredients used in medicines, quasi-drugs, OTC medicines, Chinese herbal medicines, herbal medicines, cosmetics, cosmetic materials, health foods, supplements, veterinary medicines, feeds, and the like. Specific examples of medicinal ingredients and functional ingredients include, for example, vitamin A, vitamin D, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, folic acid, biotin, niacin, pantothenic acid, iron, copper, zinc, manganese, selenium, chromium, molybdenum, polyglutamic acid, wisteria tea polyphenols, lipid regulators, antidiabetic agents, appetite suppressants, antihypertensive agents, vasodilators, β-adrenergic receptor blockers, cardiac ion channel agents, arrhythmia treatments, anticoagulants, central nervous system function improvers, sympathomimetics, parasympathomimetics, antimuscarinic agonists, dopaminergic agents, tranquilizers, antidepressants, antiepileptic agents, anti Examples of such ingredients include anxiolytics, hypnotics, stimulants, animal-derived substances, plant-derived substances, lapizin, nobiletin, sulforaphane, ampelopsin, curcumins, resveratrols, geraniol, osajin, isoliquiritigenin, hydroxytyrosol, 25-hydroxycholecalciferol, S-adenosylmethionine, anthocyanin, ascorbic acid 2-glucoside, proteoglycan, N-acetylglucosamine, collagen, bilberry extract, carrot powder, gokahi, licorice, peony root, cinnamon bark, fennel, scutellaria, bifidobacteria, lactic acid bacteria, yeast, and dietary fibers such as polydextrose. These medicinal ingredients and functional ingredients may be formulated alone or in combination of two or more.
[0023] There are no particular limitations on the excipients, so long as they are acceptable for use in pharmaceuticals, foods, veterinary drugs, feeds, and the like, and examples of the excipients include sugars, phosphates, and sulfates. Specific examples of the excipient include crystalline cellulose, lactose, sucrose, mannitol, glucose, starch, calcium phosphate, calcium sulfate, etc. These excipients may be used alone or in combination of two or more.
[0024] The binder enhances the binding strength of the powder components and is not particularly limited as long as it is acceptable for use in pharmaceuticals, foods, veterinary medicines, feed, etc. Examples of the binder include cellulose derivatives, synthetic resins, sugars, polyethers, waxes, etc. Specific examples of binders include carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, hydroxypropylcellulose, polyvinylpyrrolidone, polyvinyl alcohol, polyacrylic acid, polymethacrylic acid, glucose, sucrose, lactose, maltose, dextrin, sorbitol, mannitol, polyethylene glycol, paraffin, gum arabic, gelatin, agar, starch, pullulan, etc. These binders may be used alone or in combination of two or more.
[0025] The disintegrant disintegrates tablets or granules and enhances the absorbability of the active ingredient. There are no particular limitations on the disintegrant as long as it is acceptable for use in pharmaceuticals, foods, veterinary drugs, feeds, etc. Examples of the disintegrant include sugars, cellulose derivatives, synthetic resins, and alginates. Specific examples of disintegrants include corn starch, low-substituted hydroxypropyl cellulose, carboxymethyl cellulose calcium, crystalline cellulose, croscarmellose sodium, carboxymethyl starch sodium, polyvinylpyrrolidone, sodium alginate, etc. These disintegrants may be used alone or in combination of two or more.
[0026] The stabilizer suppresses chemical and physical decomposition of the active ingredient, and is not particularly limited as long as it is acceptable for use in pharmaceuticals, foods, veterinary drugs, feeds, and the like. Examples of the stabilizer include inorganic compounds, organic acids, organic acid salts, and vitamins. Specific examples of the stabilizer include sodium hydrogen sulfite, ascorbic acid, sodium edetate, tocopherol, etc. These stabilizers may be used alone or in combination of two or more kinds.
[0027] The preservative is not particularly limited as long as it inhibits the growth of microorganisms and is acceptable for use in pharmaceuticals, foods, veterinary medicines, feeds, and the like. Examples of the preservative include benzoates and paraoxybenzoic acid esters. Specific examples of the preservative include sodium benzoate, propyl paraoxybenzoate, methylparaben, propylparaben, etc. These preservatives may be used alone or in combination of two or more kinds.
[0028] The colorant is not particularly limited as long as it is an agent that improves palatability and distinguishability and is acceptable for use in pharmaceuticals, foods, veterinary drugs, feeds, and the like, and examples of the colorant include natural dyes and synthetic dyes. Specific examples of colorants include cochineal, carmine, curcumin, riboflavin, annatto, titanium oxide, yellow ferric oxide, ferric oxide, talc, calcined silica, magnesium carbonate, and synthetic food colorants such as Food Blue No. 1, Food Blue No. 2, Food Yellow No. 4, Food Yellow No. 5, Food Green No. 3, Food Red No. 2, Food Red No. 3, Food Red No. 102, Food Red No. 104, Food Red No. 105, and Food Red No. 106. These colorants may be blended alone or in combination of two or more.
[0029] Other flow improvers are not particularly limited as long as they are acceptable for use in pharmaceuticals, foods, veterinary medicines, feeds, etc., and examples thereof include phyllosilicate mineral powders, silicon oxides, saturated fatty acids, esters, waxes, hardened vegetable oils, fats, polyethers, etc. Specific examples of other flow improvers include talc, light anhydrous silicic acid, magnesium stearate, calcium stearate, magnesium carbonate, sodium benzoate, palmitic acid, sodium stearyl fumarate, beeswax, hardened soybean oil, cacao butter, polyethylene glycol, etc. These may be blended alone or in combination of two or more kinds.
[0030] Other additives include solubilizing agents, surfactants, emulsifiers, antioxidants, glossing agents, foaming agents, moisture-proofing agents, preservatives, fluidizing agents, sweetening agents, flavoring agents, refreshing agents, flavoring agents, fragrances, aromatics, disintegration aids, etc. Furthermore, these additives may be blended alone or in combination of two or more kinds.
[0031] [Hard capsule formulation] The hard capsule formulation of the present invention is a hard capsule formulation containing the flowability improver or powder composition of the present invention, and can be obtained by filling a powder containing the flowability improver of the present invention or the powder composition of the present invention into a hard capsule as is, or after adding the other ingredients described above. According to this, a hard capsule formulation with excellent uniformity of the filling amount of raw materials can be obtained in hard capsule filling. Furthermore, since calcium is contained, nutrition is improved. In addition, since production troubles during formulation, i.e., capsule filling, are suppressed, stable production is possible. Since calcium carbonate used as a flowability improving agent in the present invention has a nutritional supplement effect as calcium, it does not need to contain other active ingredients, but may contain other active ingredients. The shape, size, and capsule material of the hard capsule formulation of the present invention are not limited to specific ones.
[0032] [tablet] The tablet of the present invention is a tablet containing the flowability improver or powder composition of the present invention. The tablet can be obtained by compressing the powder containing the flowability improver of the present invention or the powder composition of the present invention as it is, or by adding the above-mentioned other ingredients. In addition, a sweetener, an acidulant, a flavoring, etc. may be added to make a chewable tablet. According to this, in tablet production, since the amount of raw material filled into the die is excellent in uniformity, tablets with excellent grain weight uniformity can be obtained. Furthermore, since calcium is contained, nutrition is improved. In addition, since production troubles during formulation, i.e., tableting, etc., are suppressed, stable production can be achieved. Since calcium carbonate used as a flowability improving agent in the present invention has a nutrition improving effect as calcium, it does not need to contain other active ingredients, but it may contain other active ingredients.
[0033] [Methods for improving powder flowability] The method for improving powder flowability of the present invention is characterized by adding 0.5 to 10 mass% of calcium carbonate having an average particle size of 0.4 μm or less to the total amount of powder. When calcium carbonate having an average particle size of 0.4 μm or less is contained in a powder, it exerts an excellent effect of reducing the adhesive force of powder components and improving flowability, and by further adding this at 0.5 to 10 mass%, the flowability of the powder is further improved, thereby improving the mixability of the powder and making it possible to produce a preparation with high uniformity. In addition, it is possible to reduce manufacturing problems during formulation. The method for improving flowability of the present invention exerts a remarkable effect in suppressing the occurrence of manufacturing problems in hard capsules and tablets. Furthermore, since calcium is added, nutrition can be improved.
[0034] The powder flowability improving method of the present invention can be used for powders used in applications such as medicines, foods, veterinary medicines, and feed, without any particular limitations. The composition other than the flowability improving agent or powder composition of the present invention may contain, for example, the above-mentioned active ingredients and additives, if necessary. Specific examples of additives include, for example, the above-mentioned excipients, binders, disintegrants, stabilizers, preservatives, and colorants. In addition, a flowability improving agent other than calcium carbonate having an average particle size of 0.4 μm or less may be contained. EXAMPLES
[0035] Although examples of the present invention will be described below, the present invention is not limited to these examples, and various modifications are possible within the technical concept of the present invention.
[0036] Experiment 1. Screening of flow improvers To evaluate the fluidity improving effect of calcium carbonate, 4 mass% of calcium carbonate shown in Table 1 was added to an equal mixture of crystalline cellulose (Ceolas UF-711 (Asahi Kasei)) and maltitol (Amalty MR-50 (Mitsubishi Foodtech)), and the fluidity of the powder was evaluated using a powder flow tester (BROOK FIELD). Similar experiments were also performed with conventional fluidity improvers, fine silicon dioxide, talc, and calcium silicate, for comparison (talc and calcium silicate were 4 mass%, and fine silicon dioxide was 1 mass%).
[0037] The fracture envelope was calculated from the results of the powder flow tester, and the uniaxial collapse stress and maximum principal stress were calculated from the Mohr stress tangent to the fracture envelope.The flow function (maximum principal stress / uniaxial collapse stress) was calculated from the uniaxial collapse stress value when the maximum principal stress was 7 kPa. A graph showing the change in uniaxial collapse stress versus the change in maximum principal stress due to the addition of each additive is shown in Figure 1. The ratio of maximum principal stress to uniaxial collapse stress (maximum principal stress / uniaxial collapse stress) was also calculated. A graph of the experimental results is shown in Figure 1, and the calculated flow function values are shown in Table 1. A higher flow function value indicates higher powder fluidity.
[0038] [Table 1]
[0039] As a result of the experiment, improved fluidity was observed in all powder compositions to which calcium carbonates A to D were added, compared to a powder composition without any additives. In particular, the powder composition to which calcium carbonate A was added exhibited significantly higher fluidity than the powder composition to which fine silicon dioxide, which has the highest fluidity improving effect among conventional fluidity improvers, was added. When the flow function values were compared, a significant increase in the flow function value was observed in the powder composition to which calcium carbonate A was added, indicating that calcium carbonate A has a particularly high fluidity improving effect. In addition, the repose angle value of the composition to which calcium carbonate A was added was 44°, a significant improvement in fluidity was observed compared to 47° for fine silicon oxide particles and 51° for no addition.
[0040] Experiment 2. Measurement of the average particle size of calcium carbonate The average particle size, particle morphology, and crystal properties of calcium carbonate A to D, which were found to have a fluidity improving effect in experiment 1, were measured, and the factors behind the fluidity improving effect were examined.
[0041] (Measurement of average particle size) The average particle size of calcium carbonate A to D used in experiment 1 was measured using a laser diffraction / scattering type particle size distribution analyzer (Horiba, Ltd.). The average particle size of calcium carbonate A was too small to be measured using the laser diffraction / scattering type particle size distribution analyzer, so it was measured using a zeta potential / particle size analyzer ELSZ-1000 (Otsuka Electronics Co., Ltd.). The measurement results of the average particle size are shown in Table 2.
[0042] [Table 2]
[0043] (Observation of particle morphology) The particle morphology was observed using a scanning electron microscope (Hitachi High-Technologies Corporation, Scanning Electron Microscope S-3400N). The measured image is shown in Figure 2.
[0044] (Evaluation of crystal properties) The crystal properties of calcium carbonates A to D were evaluated using a powder X-ray diffractometer MiniFlex600 (Rigaku Corporation). The measurement results are shown in Figure 3.
[0045] As a result of the above experiments, the following was observed. When the particle size was measured, it was confirmed that calcium carbonates B to D had an average particle size of micron order, while calcium carbonate A had a fine particle size of 0.04 μm, and that the average particle size was significantly different. Note that the large particles in the scanning microscope image are secondary particles of about 10 μm in size formed by the aggregation of primary particles. A comparison of particle morphology confirmed that calcium carbonate A and C were spherical particles, B was rock-like particles, and D was needle-like particles. When the crystallization characteristics were compared, no difference was observed in the measured crystallization characteristics of calcium carbonates A to D. From the above results, it was determined that the factor that caused the difference in fluidity improvement effect was the particle size of calcium carbonate, and that the influence of particle morphology and crystal characteristics on the fluidity improvement effect was small.
[0046] Experiment 3. Optimal amount of flow improver added In order to clarify the optimal amount of calcium carbonate A that was found to have a fluidity improving effect in Experiment 1, 1 to 6 mass% of calcium carbonate A was added to a powder composition consisting of an equal mixture of maltitol and crystalline cellulose (maltitol:crystalline cellulose = 50:50), and the flow characteristics of the powder were evaluated using a powder flow tester (manufactured by Brook Field Co., Ltd.) in the same manner as in Experiment 1. The results of the experiment are shown in Figure 3, and the flow function calculated from the results is shown in Table 3.
[0047] [Table 3]
[0048] From the experimental results, as shown in the graph in Figure 4, the addition of 4 mass% calcium carbonate A improved the powder fluidity the most, and the addition of 6 mass% improved the powder fluidity more than the addition of 4 mass%. The flow function value also showed the largest value when 4 mass% calcium carbonate A was added, suggesting that the powder fluidity was highly improved.
[0049] Experiment 4. Confirmation of the effect of improving flowability on powder compositions with other compositions In order to confirm that calcium carbonate A has a flowability improving effect on powder compositions other than the powder composition containing maltitol used in Experiments 1 and 3, a powder composition consisting of an equal mixture of maltitol and crystalline cellulose (maltitol: crystalline cellulose = 50: 50), a powder composition in which maltitol was replaced with ascorbic acid (L-ascorbic acid 100M (manufactured by Northeast Pharmaceutical Group)) (ascorbic acid: crystalline cellulose = 50: 50), and a powder composition in which maltitol was replaced with zinc gluconate (zinc gluconate (manufactured by Tomita Pharmaceutical Co., Ltd.)) (zinc gluconate: crystalline cellulose = 50: 50) were prepared, and 4 mass% of calcium carbonate A was added to test the flowability improving effect. The experiment and flowability measurement were performed in the same manner as in Experiment 1 above. The results of the experiment are shown in Figure 3, and the flow function values calculated from the results are shown in Table 4.
[0050] [Table 4]
[0051] As a result, the fluidity of the powder composition containing maltitol and ascorbic acid was significantly improved by adding calcium carbonate A. The fluidity of the powder composition containing zinc gluconate was also improved by adding calcium carbonate A.
[0052] Experiment 5. Confirmation of the range of average particle size that improves flowability An experiment was conducted to confirm the particle size at which calcium carbonate's fluidity improving effect appears. Calcium carbonate D was pulverized in a bead mill, and the average particle size of the pulverized material was evaluated in the same manner as in Experiment 2. The fluidity improving effect of adding 4% by mass to a powder composition consisting of an equal mixture of maltitol and crystalline cellulose (maltitol:crystalline cellulose = 50:50) was evaluated using a powder flow tester (manufactured by BROOK FIELD). For bead mill grinding, 10 g of calcium carbonate D was suspended in 100 g of water and ground using a bead mill (Dynomill MULTI LAB type, manufactured by Willy & Bachofen) under grinding conditions of beads 0.3 mm, rotation speed 8 rpm, and processing time 30 minutes. After grinding, the suspension was freeze-dried to obtain a ground product. The results of the fluidity test of the ground calcium carbonate D are shown in Figure 6, and the calculated flow function values and the measured average particle diameters are shown in Table 5.
[0053] [Table 5]
[0054] As a result of the experiment, the average particle size of the ground product of calcium carbonate D ground in a bead mill was 0.15 μm. When the flow improvement effect of the ground product was tested, the flowability of the powder was greatly improved compared to before grinding, and it was confirmed that calcium carbonate with an average particle size of 2 μm or less also has a flow improvement effect.
[0055] Experiment 6. Stability of flow improver In order to confirm that calcium carbonate in a fine state can exist stably, the stability after grinding of calcium carbonate ground was compared with that of sodium hydrogen phosphate ground. The experiment was carried out using a bead mill grinding. 10 g of calcium carbonate D or sodium hydrogen phosphate (Fujicarin (Fuji Chemical Industry Co., Ltd.)) was suspended in 100 g of water and ground using a bead mill (Dyno Mill MULTI LAB type, Willy & Bachofen Co., Ltd.) under grinding conditions of beads 0.3 mm, rotation speed 8 rpm, and processing time 30 minutes. The suspension after grinding was freeze-dried to obtain fine particles after grinding. In order to confirm the storage stability of the obtained fine particles, the average particle size was confirmed after storing at room temperature for 4 weeks. The average particle size of each particle before grinding, after grinding, and after storing for 4 weeks was measured using a dynamic light scattering (DLS) device or a laser diffraction device, and the results are shown in Table 6.
[0056] [Table 6]
[0057] Particle aggregation was confirmed for calcium hydrogen phosphate when stored for four weeks after grinding. On the other hand, no particle aggregation was observed for calcium carbonate when stored at room temperature after grinding, suggesting that it can exist stably in a fine state. Since calcium carbonate can exist stably in a fine state with an average particle size of 0.4 μm or less, which has a high fluidity improving effect, it was confirmed that calcium carbonate is a compound that is particularly suitable as a flowability improving agent. [Industrial Applicability]
[0058] The present invention can improve the fluidity of powders, which can provide pharmaceuticals such as tablets with excellent uniformity, quasi-drugs, drinkable cosmetics, drinkable cosmetics, health foods (nutritional supplements, nutritional functional foods, foods for the sick, foods for specified health uses, foods with functional claims, etc.), supplements, feeds, etc.
Claims
1. A powder flow improver comprising calcium carbonate having an average particle size of 0.4 μm or less.
2. 0.5 to 10% by mass of the powder flow improver according to claim 1; A powder composition comprising crystalline cellulose and maltitol.
3. A hard capsule formulation, characterized by containing the powder composition described in claim 2.
4. A tablet, characterized by containing the powder composition described in claim 2.
5. A method for improving the flowability of powder, comprising adding 0.5 to 10 mass % of calcium carbonate having an average particle size of 0.4 μm or less to the total amount of the powder.
Citation Information
Patent Citations
Novel use of inorganic carbonate
CN101084917A
Tablet containing atorvastatin calcium and preparation method thereof
CN110151721A
Production of vitamin c-containing hard granule
JP1992295425A
Method for mixing medicine
JP2003081876A
Rapidly disintegrating low friability tablets comprising calcium carbonate
US20070196474A1
